A new drug that slows the pace of Alzheimer's disease is too expensive for too little benefit to be used on the NHS, the watchdog says.
from BBC News https://ift.tt/S1BIUfe
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Test link
- Sitemap
- Disclaimer
- Privacy